Log in

Relevant bibliographies by topics / Macrocytosis / Journal articles

To see the other types of publications on this topic, follow the link: Macrocytosis.

Journal articles on the topic 'Macrocytosis'

Author: Grafiati

Published: 24 May 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Macrocytosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Pathak, P. K., and L. B. To. "Macrocytosis." Pathology 44 (2012): S36. http://dx.doi.org/10.1016/s0031-3025(16)32685-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Price, J. A., R. Shaarbaf, and L. A. Wood. "Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)." Journal of Clinical Oncology 25, no. 18_suppl (2007): 15580. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15580.

Full text

Abstract:

15580 Background: Sunitinib is an oral multi-targeted tyrosine kinase inhibitor with anti-tumor and anti-angiogenic activity approved and widely used for the treatment of advanced RCC. Based on a clinical observation that several RCC patients receiving Sunitinib developed macrocytosis, this study was performed to describe and examine macrocytosis in this patient population. Methods: A retrospective review of all patients treated with Sunitinib for RCC from 08/05–11/06 was performed. Data regarding hematologic parameters (e.g. CBC, mean corpuscular volume- MCV), concomitant medications, liver f

APA, Harvard, Vancouver, ISO, and other styles

3

Younes, Mohamad, Gilbert Abou Dagher, Jose V. Dulanto, Mario Njeim, and Philip Kuriakose. "Unexplained Macrocytosis." Southern Medical Journal 106, no. 2 (2013): 121–25. http://dx.doi.org/10.1097/smj.0b013e3182824cdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sechi, Leonardo A., Stefano De Carli, and Ettore Bartoli. "Familial macrocytosis." American Journal of Hematology 46, no. 3 (1994): 253. http://dx.doi.org/10.1002/ajh.2830460323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yu, Inski, Richard N. Greenberg, Timothy N. Crawford, Alice C. Thornton, and Thein Myint. "Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients." Journal of the International Association of Providers of AIDS Care (JIAPAC) 16, no. 5 (2017): 512–15. http://dx.doi.org/10.1177/2325957417702486.

Full text

Abstract:

The duration of macrocytosis after stopping zidovudine (ZDV) is unknown. Among 104 HIV-infected patients treated with ZDV for more than 1 year, 84 patients had macrocytosis at ZDV discontinuation. The median mean corpuscular volume (MCV) was 114.6 fL (range 100-128 fL). Patients were divided into 2 groups: those who did (resolved macrocytosis, n = 36) and did not (persistent macrocytosis, n = 48) normalize MCV at 3 to 6 months after ZDV discontinuation. Alcohol use ( P = .02), smoking ( P = .03), and lower (but within normal range) folic acid levels ( P = .05) were related to the persistence o

APA, Harvard, Vancouver, ISO, and other styles

6

Bourlon, Maria Teresa, Dexiang Gao, Sara Trigero, Julia Elizabeth Clemons, Elaine Tat Lam, and Thomas W. Flaig. "Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma." Journal of Clinical Oncology 33, no. 7_suppl (2015): 453. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.453.

Full text

Abstract:

453 Background: Increases in mean corpuscular volume (MCV) and hypothyroidism have been observed in patients on sunitinib treatment. We characterized tyrosine kinase-associated macrocytosis in metastatic renal cell carcinoma (mRCC) patients and its relationship, along with thyroid dysfunction, to progression-free survival (PFS). Methods: A retrospective chart review was performed on patients treated with sunitinib and/or sorafenib (01/2005-01/2011). Data pertaining to the development of macrocytosis was analyzed in association with our previous data on thyroid dysfunction in these patients. We

APA, Harvard, Vancouver, ISO, and other styles

7

Sarbay, Hakan. "Evaluation of hematological findings in children with Down syndrome." International Journal of Contemporary Pediatrics 5, no. 5 (2018): 1724. http://dx.doi.org/10.18203/2349-3291.ijcp20183506.

Full text

Abstract:

Background: Various hematological disorders and malignancies may be encountered with Down syndrome. In this article, hematological findings of children with Down syndrome were investigated.Methods: The hematological results of 106 Down syndrome children aged 3 months to 17 years were assessed retrospectively. The results were compared with a patient group consisting of non-DS and healthy children with a similar age range.Results: When compared with the control group, a significant difference was found between the frequencies of neutropenia, monocytosis, macrocytosis and anisocytosis. No signif

APA, Harvard, Vancouver, ISO, and other styles

8

Hands, D. J., B. Eccles, and T. R. Geldart. "An underinvestigated toxicity of sunitinib: Red cell macrocytosis." Journal of Clinical Oncology 29, no. 7_suppl (2011): 371. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.371.

Full text

Abstract:

371 Background: Sunitinib, a multitargeted receptor tyrosine kinase inhibitor represents a standard firstline therapy for advanced renal cell carcinoma. Red blood cell (RBC) macrocytosis (with or without anaemia) is a recognized haematological toxicity but its aetiology remains uncertain. Methods: The medical records of 73 patients (55 male, 18 female) patients treated with sunitinib between 2007 and 2010 at Poole and Bournemouth NHS Trusts, UK were reviewed. Patient demographics, length of treatment, response, RBC mean cell volume (MCV) indices, and known causes of macrocytosis including B12

APA, Harvard, Vancouver, ISO, and other styles

9

Vega, Jose, Mohamad Younes, and Philip Kuriakose. "The Significance of Unexplained Macrocytosis." Blood 112, no. 11 (2008): 3449. http://dx.doi.org/10.1182/blood.v112.11.3449.3449.

Full text

Abstract:

Abstract Background: Macrocytosis is a relatively common finding in adult patients undergoing automated complete blood cell (CBC) counting with an incidence varying from 1.7 % to 3.6 %. Approximately 60% will not have associated anemia. Causes of macrocytosis include alcohol intake, vitamin B12 and folate deficiency, chemotherapy and other drugs, hemolysis or bleeding, liver dysfunction, myelodysplastic syndrome (MDS), and hypothyroidism. Approximately 10% of patients will have unexplained macrocytosis after laboratory evaluation. Data on the diagnostic approach and management of patients with

APA, Harvard, Vancouver, ISO, and other styles

10

Pappo, Alberto S., Barbara W. Fields, and George R. Buchanan. "Etiology of Red Blood Cell Macrocytosis During Childhood: Impact of New Diseases and Therapies." Pediatrics 89, no. 6 (1992): 1063–67. http://dx.doi.org/10.1542/peds.89.6.1063.

Full text

Abstract:

Although an elevated erythrocyte mean corpuscular volume has been noted in many conditions, the relative frequency of various causes of macrocytosis in the pediatric population has not been defined. Therefore, the different medical conditions associated with red cell macrocytosis were retrospectively reviewed. One hundred forty-six children between 6 months and 12 years of age with a mean corpuscular volume ≥ 90 fL were identified during a 13-month period. The most common association with macrocytosis was drug ingestion (anticonvulsants, zidovudine, immunosuppressive agents), observed in 51 (3

APA, Harvard, Vancouver, ISO, and other styles

11

Crellin, RF, T. Bottiglieri, and EH Reynolds. "Macrocytosis in MS." Acta Neurologica Scandinavica 82, no. 6 (2009): 397. http://dx.doi.org/10.1111/j.1600-0404.1990.tb03325.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

SPIER, STANLEY, LAWRENCE M. SOLOMON, NANCY B. ESTERLY, and WALTER FRIED. "Hydroxyurea and macrocytosis." British Journal of Dermatology 89, no. 2 (2006): 199–205. http://dx.doi.org/10.1111/j.1365-2133.1973.tb02957.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ahmad, S., and A. Sukthankar. "Stavudine induced macrocytosis." Sexually Transmitted Infections 73, no. 5 (1997): 421. http://dx.doi.org/10.1136/sti.73.5.421.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

SECHI, L. A., S. DE CARLI, C. CATENA, L. ZINGARO, and E. BARTOLI. "Benign familial macrocytosis." Clinical & Laboratory Haematology 18, no. 1 (1996): 41–43. http://dx.doi.org/10.1111/j.1365-2257.1996.tb00736.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

O'Reilly, Maeve A., Claire M. Buckley, Janas M. Harrington, Susan O'Shea, Ivan J. Perry, and Mary R. Cahill. "Cigarette Smoking Is An Under Recognised Cause Of Macrocytosis." Blood 122, no. 21 (2013): 4660. http://dx.doi.org/10.1182/blood.v122.21.4660.4660.

Full text

Abstract:

Introduction The prevalence of macrocytosis in adults is estimated between 1.7% and 8% (Aslinia F et al. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006; 4: 236-241, McNamee et al. Haematinic deficiency and macrocytosis in middle aged and older adults. 2013 Submitted PLOS ONE). Its diagnosis, depending on the clinical context, may warrant an extensive work-up for a vitamin deficiency or haematological malignancy. Known associations with raised mean corpuscular volume (MCV) include haematinic deficiency, heavy alcohol intake, liver disease, myelodysplasia and myeloma.

APA, Harvard, Vancouver, ISO, and other styles

16

McMurran, A. E. L., and R. A. Adair. "Macrocytosis and sudden sensorineural hearing loss: a case report." Journal of Laryngology & Otology 129, no. 11 (2015): 1137–39. http://dx.doi.org/10.1017/s0022215115002340.

Full text

Abstract:

AbstractBackground:Although other blood dyscrasias are known to cause sudden sensorineural hearing loss, macrocytosis has not previously been implicated in the absence of another causative agent.Case report:We present a case of bilateral sequential sudden sensorineural hearing loss in a patient with significant macrocytosis (mean corpuscular volume at presentation 124 fl) secondary to alcohol-induced liver dysfunction.Conclusion:A possible pathophysiological mechanism linking macrocytosis and sudden sensorineural hearing loss was identified, suggesting areas for further investigation.

APA, Harvard, Vancouver, ISO, and other styles

17

Thimmappa, Nalina, Vijeth S. B., Prashanth G., and Sreedevi B. K. "Evaluation of clinical, biochemical and hematological parameters in macrocytic anemia." International Journal of Advances in Medicine 6, no. 2 (2019): 489. http://dx.doi.org/10.18203/2349-3933.ijam20191164.

Full text

Abstract:

Background: Macrocytosis can be seen in many hematological and non-hematological disorders and more than one cause may co-exist in an individual. Serum vitamin B12 and folic acid tests are routinely ordered but they are limited by their low sensitivity and specificity. This study is done to analyze the clinical, hematological and biochemical parameters in macrocytic anemia and to study the difference between megaloblastic and non-megaloblastic anemia in these parameters.Methods: There were 100 patients presenting with macrocytosis were taken in to study. A detailed clinical history and physica

APA, Harvard, Vancouver, ISO, and other styles

18

Almugbel, Fahad, Laith Al-Showbaki, Michelle Nadler, Alexandra Desnoyers, Ramy Saleh, and Eitan Amir. "Macrocytosis as a predictor of response to capecitabine in solid cancers: A meta-analysis." Journal of Clinical Oncology 38, no. 15_suppl (2020): e13080-e13080. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13080.

Full text

Abstract:

e13080 Background: Capecitabine is an effective oral chemotherapy that is widely used in a number of solid cancers both as monotherapy or in combination with other anti-cancer drugs. It has been suggested that mean corpuscular volume (MCV) is associated with response to capecitabine. Methods: We searched PubMed for studies exploring the association between capecitabine and macrocytosis or MCV. We extracted the hazard ratios (HR) reporting progression-free (PFS) or overall survival (OS) data when comparing macrocytosis to normal/low MCV. If HR were not directly reported, we estimated them from

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Sunitinib-induced macrocytosis highlighted." Reactions Weekly &NA;, no. 1172 (2007): 4. http://dx.doi.org/10.2165/00128415-200711720-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Sunitinib-induced macrocytosis highlighted." Inpharma Weekly &NA;, no. 1608 (2007): 21. http://dx.doi.org/10.2165/00128413-200716080-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Crellin, R. F., T. Bottiglieri, and E. H. Reynolds. "Multiple sclerosis and macrocytosis." Acta Neurologica Scandinavica 81, no. 5 (2009): 388–91. http://dx.doi.org/10.1111/j.1600-0404.1990.tb00981.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Crellin, R. F., T. Bottiglieri, and E. H. Reynolds. "MULTIPLE SCLEROSIS AND MACROCYTOSIS." Lancet 334, no. 8672 (1989): 1157. http://dx.doi.org/10.1016/s0140-6736(89)91521-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

O'Reilly, Maeve A., Janas M. Harrington, Claire M. Buckley, Susan O'Shea, Ivan J. Perry, and Mary R. Cahill. "Macrocytosis: A Metabolic Marker?" Blood 122, no. 21 (2013): 4663. http://dx.doi.org/10.1182/blood.v122.21.4663.4663.

Full text

Abstract:

Introduction The metabolic syndrome (MS) as a disease entity rarely captures the attention of a clinical haematologist. The prevalence of the MS in the Irish population is estimated at 20% (Villegas et al. Prevalence and lifestyle determinants of the metabolic syndrome. Ir Med J. 2004; 97(10): 300-303). While insulin resistance is implicated, the pathogenesis uniting the components of the syndrome remains unclear. In an additional study from our group (O’Reilly et al. Submitted ASH 2013), we demonstrated an independent association between the MS and clinically significant macrocytosis (mean co

APA, Harvard, Vancouver, ISO, and other styles

24

Mukhopadhyay, Asima, Neerja Bhatla, Alka Kriplani, and Renu Saxena. "Physiological macrocytosis of pregnancy." Tropical Doctor 37, no. 1 (2007): 42–43. http://dx.doi.org/10.1258/004947507779952104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Rizeq, M., S. K. Sinha, and M. N. Zaman. "Macrocytosis in elderly patients." Age and Ageing 26, no. 3 (1997): 237–38. http://dx.doi.org/10.1093/ageing/26.3.237-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

POSER, C. "Macrocytosis and multiple sclerosis." Lancet 335, no. 8680 (1990): 50. http://dx.doi.org/10.1016/0140-6736(90)90174-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Zygulska, Lidia, and Krzysztof Krzemieniecki. "Increased mean corpuscular volume as a predictor of response during bevacizumab treatment." Archive of Oncology 20, no. 1-2 (2012): 15–16. http://dx.doi.org/10.2298/aoo1202015z.

Full text

Abstract:

Background: Remission during sunitinib (a multikinase inhibitor and antiangiogenic drug) treatment correlates with appearance of macrocytosis. There are some suggestions that bevacizumab, an antiangiogenic drug, may result in macrocytosis as well. There are no published data available on the influence of bevacizumab on macrocytosis. This paper attempted to answer the question: does bevacizumab induce macrocytosis being a predictor of the response? Methods: Between August 2008 and August 2011, 53 patients (29 male and 24 female) were treated with bevacizumab in the combination with chemotherapy

APA, Harvard, Vancouver, ISO, and other styles

28

Sweet, Kendra L., Najla H. Al Ali, Rami S. Komrokji, Jeffrey E. Lancet, and Javier Pinilla-Ibarz. "Macrocytosis and Iron Stores in Patients with Chronic Myeloid Leukemia Being Treated with Tyrosine Kinase Inhibitors." Blood 120, no. 21 (2012): 2769. http://dx.doi.org/10.1182/blood.v120.21.2769.2769.

Full text

Abstract:

Abstract Abstract 2769 Background: Since imatinib was approved in 2001, tyrosine kinase inhibitors (TKIs) have become standard of care for first line treatment of Chronic Myeloid Leukemia (CML). Macrocytosis has been observed in some patients being treated with imatinib but the etiology of this phenomenon is unclear. Altered DNA metabolism resulting from the inhibition of c-kit by imatinib may be an explanation but anecdotal correction of macrocytic anemia after iron replacement has prompted us to explore this further. The correlation between bone marrow iron stores, anemia and macrocytosis ha

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Macrocytosis multifactorial in sunitinib recipients." Reactions Weekly &NA;, no. 1343 (2011): 3. http://dx.doi.org/10.2165/00128415-201113430-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Walter A. Eyer-Silva, Juçara Árabe,. "Macrocytosis in Patients on Stavudine." Scandinavian Journal of Infectious Diseases 33, no. 3 (2001): 239–40. http://dx.doi.org/10.1080/00365540151061067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Prasher, V. P. "DOWN SYNDROME, DEMENTIA AND MACROCYTOSIS." British Journal of Development Disabilities 40, no. 79 (1994): 131–34. http://dx.doi.org/10.1179/bjdd.1994.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Conrado, Francisco O., Amy L. Weeden, Abbie L. Speas, and Mary K. Leissinger. "Macrocytosis secondary to hydroxyurea therapy." Veterinary Clinical Pathology 46, no. 3 (2017): 451–56. http://dx.doi.org/10.1111/vcp.12511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Horstman, Andrew L., Stephanie L. Serck, and Ronald S. Go. "Macrocytosis associated with monoclonal gammopathy." European Journal of Haematology 75, no. 2 (2005): 146–49. http://dx.doi.org/10.1111/j.1600-0609.2005.00441.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Brigden, Malcolm L. "A systematic approach to macrocytosis." Postgraduate Medicine 97, no. 5 (1995): 171–86. http://dx.doi.org/10.1080/00325481.1995.11945999.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Breedveld, Ferdinand C., Robert Bieger, and Robert K. A. Wermeskerken. "The Clinical Significance of Macrocytosis." Acta Medica Scandinavica 209, no. 1-6 (2009): 319–22. http://dx.doi.org/10.1111/j.0954-6820.1981.tb11599.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Tsivkin, Ruth, Ema Saito, and Vivian Kafantaris. "Macrocytosis Associated with Divalproex Treatment." Journal of Child and Adolescent Psychopharmacology 15, no. 6 (2005): 1011–14. http://dx.doi.org/10.1089/cap.2005.15.1011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Prasher, Vee, Jay Viswanathan, and Roger Holder. "Down's syndrome, dementia and macrocytosis." Irish Journal of Psychological Medicine 19, no. 4 (2002): 115–20. http://dx.doi.org/10.1017/s079096670000728x.

Full text

Abstract:

AbstractObjective: No definitive peripheral biological marker has yet been found to correlate with Alzheimer's disease (AD). This study investigated the role of macrocytosis as a marker which could significantly improve our understanding of AD in the Down's syndrome (DS) population.Methods: This study investigated the possible association between raised mean corpuscular volume (MCV) and AD in 150 adults with DS over a five year study period.Results: A raised MCV is common in the DS population. A statistically significant association between a further elevated MCV and clinically diagnosed AD in

APA, Harvard, Vancouver, ISO, and other styles

38

Chanarin, I. "Macrocytosis--how far to investigate?" Postgraduate Medical Journal 63, no. 743 (1987): 765–66. http://dx.doi.org/10.1136/pgmj.63.743.765.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

MAHMOUD, M. Y., M. LUGON, and C. C. ANDERSON. "Unexplained Macrocytosis in Elderly Patients." Age and Ageing 25, no. 4 (1996): 310–12. http://dx.doi.org/10.1093/ageing/25.4.310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Salinas, Maria, Emilio Flores, Maite López-Garrigós, and Carlos Leiva-Salinas. "High frequency of anti-parietal cell antibody (APCA) and intrinsic factor blocking antibody (IFBA) in individuals with severe vitamin B12 deficiency – an observational study in primary care patients." Clinical Chemistry and Laboratory Medicine (CCLM) 58, no. 3 (2020): 424–29. http://dx.doi.org/10.1515/cclm-2019-0749.

Full text

Abstract:

AbstractBackgroundVitamin B12 deficiency is common worldwide and is also linked to several diseases including autoimmune atrophic gastritis (AAG). The presence of anti-parietal cell antibodies (APCA) and/or intrinsic factor blocking antibodies (IFBA) is indicative of AAG that may develop into pernicious anemia. Both conditions are known to be associated with an increased risk of gastric carcinoma. The aim of this study was to estimate the frequency of individuals positive for APCA and IFBA antibodies in primary care patients with severe vitamin B12 deficiency.MethodsAn observational study was

APA, Harvard, Vancouver, ISO, and other styles

41

G, Mamatha. "To Study Hematological Features in Various Etiologies of Macrocytic Anemias." Journal of Medical Science And clinical Research 11, no. 07 (2023): 27–35. http://dx.doi.org/10.18535/jmscr/v11i7.05.

Full text

Abstract:

Background: Mean corpuscular volume (MCV) increases by more than 100 fl. in macrocytosis, a condition in which erythrocytes are larger than normal. The purpose of this study was to evaluate the haematological characteristics in various aetiologies and to determine the underlying reasons of macrocytosis, which was found in regular hemograms. In addition to doing full blood counts, renal function tests, liver function tests, vitamin B12 assays, folate assays, and peripheral smear evaluations and few case were bone marrow examination. Material and Methods: In this prospective observational study

APA, Harvard, Vancouver, ISO, and other styles

42

Dangare, Harsha, Jaison Janice, and Murgod PS. "RDW-SD - A more sensitive marker of anisocytosis than RDW-CV in patients with macrocytosis." Journal of Pathology of Nepal 14, no. 1 (2024): 2130–34. http://dx.doi.org/10.3126/jpn.v14i1.55709.

Full text

Abstract:

Background: Anisocytosis is a variation in RBC size. This can be conventionally observed on peripheral blood smear microscopy and also by red cell distribution width, a RBC parameter obtained on automated hematology analyzers. Red cell distribution width is considered a quantitative measure of anisocytosis and does not carry subjective variation associated with microscopy and it is reported as RDW-CV % and RDW-SD. Both these values are calculated differently. Although it is one of the most frequently used hemogram parameters for anisocytosis, it is not well understood. This study aimed to comp

APA, Harvard, Vancouver, ISO, and other styles

43

Clemency, Nye, Latimer Joanna, and Gompels Mark. "Macrocytosis Associated with Lamivudine and Emtricitabine Use in Patients with HIV." Journal of AIDS & Clinical Research 12, no. 1 (2021): 4. https://doi.org/10.5281/zenodo.10020532.

Full text

Abstract:

Objectives: The aim of the study was to evaluate the effect of lamivudine on the erythrocyte mean corpuscular volume. Methods: We conducted a retrospective evaluation of the mean corpuscular volume in patients prescribed lamivudine, and a comparison group of patients not taking lamivudine or other NRTIs known to affect the MCV, using electronic patient records from a single UK centre. Results: A total of 456 patients whilst on lamivudine were compared to 483 patients not having taken lamivudine. The mean MCV in the lamivudine group was 94.1 (83-100 fl)., which was statistically significantly h

APA, Harvard, Vancouver, ISO, and other styles

44

Chambers, Daniel Charles, Belinda Edith Clarke, Julie McGaughran, and Christine Kim Garcia. "Lung Fibrosis, Premature Graying, and Macrocytosis." American Journal of Respiratory and Critical Care Medicine 186, no. 5 (2012): e8-e9. http://dx.doi.org/10.1164/rccm.201112-2175im.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Tsantes, Argirios E., Stefanos Bonovas, Anthi Travlou, and Nikolaos M. Sitaras. "Redox Imbalance, Macrocytosis, and RBC Homeostasis." Antioxidants & Redox Signaling 8, no. 7-8 (2006): 1205–16. http://dx.doi.org/10.1089/ars.2006.8.1205.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

WATSON, ADJ, and PJ CANFIELD. "Macrocytosis in poodles — appeal for cases." Australian Veterinary Journal 65, no. 8 (1988): 260. http://dx.doi.org/10.1111/j.1751-0813.1988.tb14317.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Burns, Edward R., L. Juden Reed, and Barry Wenz. "Volumetric Erythrocyte Macrocytosis Induced by Hydroxyurea." American Journal of Clinical Pathology 85, no. 3 (1986): 337–41. http://dx.doi.org/10.1093/ajcp/85.3.337.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Savage, David G., Akinola Ogundipe, John Lindenbaum, Sally P. Stabler, and Robert Hallen. "Etiology and Diagnostic Evaluation of Macrocytosis." American Journal of the Medical Sciences 319, no. 6 (2000): 343–52. http://dx.doi.org/10.1016/s0002-9629(15)40772-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Yu, Eric, Richard Feinn, Robert Bona, et al. "Mild macrocytosis in Williams-Beuren syndrome." European Journal of Medical Genetics 63, no. 3 (2020): 103740. http://dx.doi.org/10.1016/j.ejmg.2019.103740.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Seppä, K., K. Heinilä, P. Sillanaukee, and M. Saarni. "Evaluation of macrocytosis by general practitioners." Journal of Studies on Alcohol 57, no. 1 (1996): 97–100. http://dx.doi.org/10.15288/jsa.1996.57.97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!